5.0
Mar 16, 2018
Anonymous employee
Current employee
Recommend
CEO approval
Business Outlook
Pros
Growing company with lots of opportunity for internal development. Offers exposure to cross-section of the pharma industry to gain exposure to full scope of drug and device-development sponsors.
Cons
Growing mid-sized company that is working on developing pipeline and supporting infrastructure at the right pace. Some growing-pains associated with that challenge, but consistent growth year over year is a good indicator of quality and developing business.